HUS to primarily deliver patient letters electronically
21.10.2026 07:30:00 EEST | HUS | Press release
HUS will start using Suomi.fi messages on October 26, 2026. From that date onward, letters to patients over the age of 18 are delivered to Maisa, Suomi.fi messages, or OmaPosti. Patients who have not enabled electronic services will continue to receive paper letters.

Starting on October 26, 2026, HUS will begin delivering patient letters for adult patients electronically. The primary delivery channel is Maisa, which also provides access to other health information.
If a patient has not activated Maisa, the letter will be delivered to their Suomi.fi messages or OmaPosti. If the patient has not activated electronic letters in Maisa, the letter will be delivered to Suomi.fi messages or OmaPosti in addition to Maisa. If the patient does not use any of these electronic services, the letter will be sent as paper mail.
If the patient has enabled text messages in Maisa, they will receive a text message about an appointment booking and a reminder two days before the appointment.
This change in the delivery method of patient letters does not apply to persons under guardianship or persons with a valid continuing power of attorney, underage patients, or client invoices. Depending on the patient’s choice, invoices will be sent as e-invoices, through OmaPosti or direct payment, or by mail.
Electronic letters offer many benefits
Electronic letters are convenient to access without the delays associated with paper mail. They also help reduce mailing costs and conserve the environment.
Switching to electronic letters is part of a nationwide shift towards digital communications by the authorities.
“We expect the change to generate significant savings. We estimate that the number of paper letters will be reduced by half, resulting in savings of more than one million euros. These funds can be redirected to carrying out HUS’ core task, which is treating patients,” says Administrative Chief Medical Officer Teppo Heikkilä.
HUS website has instructions on how to enable electronic letters and text message reminders in Maisa (https://www.hus.fi/en/e-services).
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats 700,000 patients every year. Our 26,500 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Sammanslutningens styrelse valde HUS nya leverantör av bilddiagnostisk lösning5.10.2026 13:16:05 EEST | Pressmeddelande
På sitt möte valde sammanslutningens styrelse HUS nya leverantör av bilddiagnostisk lösning och behandlade verksamheten och ekonomin för januari–augusti 2026.
Yhtymähallitus valitsi HUSin kuvantamisratkaisun toimittajan5.10.2026 13:16:05 EEST | Tiedote
Yhtymähallitus valitsi kokouksessaan HUSin kuvantamisratkaisun toimittajan sekä käsitteli tammi−elokuun 2026 toimintaa ja taloutta.
Studie gav ny kunskap om immunförsvaret vid leukemi29.9.2026 08:26:54 EEST | Pressmeddelande
Forskare vid HUS Cancercentrum och Helsingfors universitet utredde hur immunsystemet hos patienter med akut myeloisk leukemi reagerade på experimentell immunterapi. Förändringar som hänför sig till terapiresponsen visade sig i andra immunceller än förväntat baserat på tidigare studier.
Tutkimus toi uutta tietoa leukemian immuunipuolustuksesta29.9.2026 08:26:54 EEST | Tiedote
HUSin Syöpäkeskuksen ja Helsingin yliopiston tutkijat selvittivät, miten akuuttia myelooista leukemiaa sairastavien potilaiden immuunijärjestelmä reagoi kokeelliseen immunoterapiaan. Hoitovasteeseen liittyvät muutokset näkyivät eri immuunisoluissa kuin aiempien tutkimusten perusteella olisi voitu odottaa.
Study provides new insights into the immune response in leukemia29.9.2026 08:26:54 EEST | Press release
Researchers at HUS Comprehensive Cancer Center and the University of Helsinki investigated how the immune systems of patients with acute myeloid leukemia (AML) respond to experimental immunotherapy. The study found that changes associated with treatment response were observed in different immune cell types than would have been expected based on previous research.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom